Tg Therapeutics (TGTX) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for Tg Therapeutics (TGTX) over the last 7 years, with Sep 2025 value amounting to -$6.5 million.
- Tg Therapeutics' Other Gross PP&E Adjustments rose 12.28% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.3 million, marking a year-over-year increase of 12.03%. This contributed to the annual value of -$7.2 million for FY2024, which is 11.17% up from last year.
- As of Q3 2025, Tg Therapeutics' Other Gross PP&E Adjustments stood at -$6.5 million, which was up 3.23% from -$6.7 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Other Gross PP&E Adjustments registered a high of -$6.5 million during Q3 2025, and its lowest value of -$9.1 million during Q1 2021.
- For the 3-year period, Tg Therapeutics' Other Gross PP&E Adjustments averaged around -$7.6 million, with its median value being -$7.7 million (2024).
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first fell by 3.36% in 2022, then rose by 12.38% in 2025.
- Over the past 5 years, Tg Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$8.6 million in 2021, then declined by 3.00% to -$8.9 million in 2022, then climbed by 9.43% to -$8.1 million in 2023, then grew by 11.17% to -$7.2 million in 2024, then grew by 12.28% to -$6.5 million in 2025.
- Its Other Gross PP&E Adjustments was -$6.5 million in Q3 2025, compared to -$6.7 million in Q2 2025 and -$6.9 million in Q1 2025.